Regatta Capital Group »

Allogene Therapeutics shares owned by Regatta Capital Group

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Regatta Capital Group from 13F filings

Historical chart of Regatta Capital Group investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Regatta Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Regatta Capital Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $42k 20k 2.08

More positions owned by Regatta Capital Group

Ishares Tr Core S&p Ttl Stk (ITOT)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
American Centy Etf Tr Avantis Core Fi (AVIG)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Core Msci Total (IXUS)
Capital Grp Fixed Incm Etf T Us Multi-sector (CGMS)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard World Esg Us Stk Etf (ESGV)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)

View all positions for Regatta Capital Group

Top funds holding Allogene Therapeutics

BlackRock
Frazier Life Sciences Management
Pfizer
Tpg Gp A
Sio Capital Management
PRIMECAP Management Company
Vanguard Capital Management
FMR
Citadel Advisors
State Street Corporation
Two Sigma Investments
Geode Capital Management
Goldman Sachs Group
T. Rowe Price Associates
Marshall Wace

View all funds holding Allogene Therapeutics